Key result
Stock market gains show no significant overall link to acute cardiovascular mortality.
Why the study?
Stock volatility can cause acute stress for stockholders, potentially triggering cardiovascular events, but its short-term effect on cardiovascular mortality and stroke has not been systematically quantified.
Meta-Analysis
Effect estimate: 1.01% increase (95% CI -0.18 to 2.21)
Does not support direct stock market effects on cardiovascular mortality; leaves open lagged stroke associations for prospective confirmation.
INTRODUCTION: Cardiovascular diseases (CVD) and stroke are leading causes of death. It has several risk factors including stress and pressure. Stock volatility can cause acute stress for stock holders, so it can cause CVD events. Recently the spread of new coronaviruses worldwide has greatly affected economic development, leading to more severe stock market fluctuation, so we systematically quantify the short-term effect of stock volatility and CVD events.METHODS AND MATERIALS: Time-series analysis on effect of stock volatility and cardiovascular events were included. We conducted systematic review and meta-analysis. 4 studies were included in the final analysis.RESULTS: Every 100-point increase in the stock market will bring about 1.01% increases in the cardiovascular mortality (95% CI, -0.18% to 2.21%) The meta-analysis showed no statistical significance for cardiovascular mortality. In terms of stroke event, the estimate effect was 2.999% (95%CI, 0.325% to 5.673%). Different lag patterns also had effects on cardiovascular mortality. Every 100-point increase brought about 4.026% (95%CI, 1.516% to 6.536%) and 4.424% (95%CI, 1.145% to 7.703%) for lag 01 and 04 separately. Conclusions: Our study suggested that stock volatility had lag effect on CVD mortality. It may last for several days. Also, it might increase the incidence of stroke.
No takes yet. Share an insight, caveat, or question.
Lian et al. (2020) conducted a meta-analysis in Cardiovascular mortality. Stock market volatility vs. Baseline stock market levels was evaluated on Cardiovascular mortality (1.01% increase, 95% CI -0.18 to 2.21). Every 100-point increase in the stock market was associated with a non-significant 1.01% increase in cardiovascular mortality, though cumulative lag effects and stroke events showed significant increases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: